About Imanova
Imanova is a company based in London (United Kingdom) founded in 2011 was acquired by Invicro in September 2017. Imanova offers products and services including Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry. Imanova operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imanova Limited
- Date of Incorporation 03 Feb, 2011
- Jurisdiction LONDON, UNITED KINGDOM
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imanova
Imanova offers a comprehensive portfolio of products and services, including Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry.
Delivers high-quality imaging data for clinical trials worldwide.
Conducts independent reviews of trial event assessments by experts.
Supports imaging study designs for pharmaceutical R&D needs.
Offers RTSM solutions for efficient clinical trial operations.
Provides radiolabeling for agents in drug development processes.
Funding Insights of Imanova
Investors in Imanova
Imanova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Invicro and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Provide contract research imaging services and software
|
Locked | Locked | Locked |
Investor details for Imanova
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imanova
Investment portfolio details for Imanova
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imanova
Detailed financials for Imanova
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imanova Comparisons
Peer comparison for Imanova
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imanova
Imanova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
Detailed competitors of Imanova
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imanova
Complete news archive for Imanova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imanova
Imanova was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Imanova is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Imanova, acquired by US-based Invicro in September 2017, enables the study of the absorption, distribution, metabolism and excretion of drugs through their expertise in radiolabeling of drug candidates and Positron Emission Tomography (PET) imaging. They also offer services for visualising the candidate target engagement in vivo through PET imaging. The company also offers MRI services. Founded as a joint venture between UKs Medical Research Council and three London universities - the Imperial College London, Kings College London and University College London, the company offers preclinical and clinical imaging and novel imaging biomarker development services. Imanova claims to have developed and implemented 21 imaging biomarkers according to GMP standards since its inception. The company offer imaging biomarker development services mainly for therapeutic areas such as neurosciences, oncology, inflammation, cardiology and respiratory diseases.
Imanova's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Imanova offers Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry.
Imanova has 2 investors. Key investors include Invicro, and European Union.